ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 250 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132 | +34.7% | 6,361 | +54.2% | 0.00% | – |
| Q2 2023 | $98 | +71.9% | 4,125 | +35.8% | 0.00% | – |
| Q1 2023 | $57 | -99.9% | 3,037 | -17.7% | 0.00% | – |
| Q3 2022 | $60,000 | -16.7% | 3,689 | +18.4% | 0.00% | – |
| Q4 2021 | $72,000 | +67.4% | 3,115 | +19.4% | 0.00% | – |
| Q3 2021 | $43,000 | -40.3% | 2,609 | +92.4% | 0.00% | – |
| Q4 2020 | $72,000 | +30.9% | 1,356 | 0.0% | 0.00% | – |
| Q3 2020 | $55,000 | -67.8% | 1,356 | -66.6% | 0.00% | – |
| Q1 2020 | $171,000 | -93.5% | 4,060 | -93.4% | 0.00% | -100.0% |
| Q4 2019 | $2,645,000 | +9020.7% | 61,846 | +7488.5% | 0.00% | – |
| Q3 2019 | $29,000 | – | 815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |